All In Biotech

Drug Trial Radar · NCT06909162

A Study to Evaluate the Effect of Food on the Single-Dose Pharmacokinetics and a Drug-Drug Interaction Evaluation of Itraconazole and Carbamazepine on INCB123667 When Administered Orally to Healthy Adult Participants

A Phase 1, Open-Label Study to Evaluate the Effect of Food on the Single-Dose Pharmacokinetics and a Drug-Drug Interaction Evaluation of Itraconazole and Carbamazepine on INCB123667 When Administered Orally to Healthy Adult Participants

Last checked: Nov 20, 2026Latest source record: Jun 15, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

51

Actual

Start

May 5, 2025

Primary completion

May 17, 2026

Study completion May 17, 2026

Sponsor

Lead sponsor
Incyte CorporationIncyte (INCY)
Sponsor type
Industry
First posted
Apr 3, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Crossover
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 19 years, up to 55 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This study will be conducted to evaluate the effect of food on the single-dose pharmacokinetics and a drug-drug interaction evaluation of itraconazole and carbamazepine on INCB123667 when administered orally to healthy adult participants.

Conditions

  • Healthy Participants

Interventions

  • INCB123667Drug

    single dose administered orally

  • itraconazoleDrug

    Oral: Tablet

  • carbamazepineDrug

    Oral; Tablet

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Pharmacokinetics Parameter (PK): Cmax of INCB123667Time frame: Up to Day 16
  2. Pharmacokinetics Parameter: Tmax of INCB123667Time frame: Up to Day 16
  3. Pharmacokinetics Parameter: AUCt of INCB123667Time frame: Up to Day 16
  4. Pharmacokinetics Parameter: AUC∞ of INCB123667Time frame: Up to Day 16

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Celerion, Inc

    Lincoln, Nebraska

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.